Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends

por Nepali, Kunal, Liou, Jing-Ping
Publicado 2021

Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal

por Nepali, Kunal, Sharma, Ram, Sharma, Sachin, Thakur, Amandeep, Liou, Jing-Ping
Publicado 2022

Glioblastoma: Current Status, Emerging Targets, and Recent Advances

por Thakur, Amandeep, Faujdar, Chetna, Sharma, Ram, Sharma, Sachin, Malik, Basant, Nepali, Kunal, Liou, Jing Ping
Publicado 2022

Protective effect of Grewia asiatica leaves extract in animal models of epilepsy and anxiety

por Kaur, Shabnampreet, Singh, Atamjit, Singh, Hasandeep, Singh Bedi, Preet Mohinder, Nepali, Kunal, Singh, Balbir, Kaur, Sarabjit
Publicado 2022

Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitors

por Kumar, Sunil, Mehndiratta, Samir, Nepali, Kunal, Gupta, Manish K, Koul, Surrinder, Sharma, Parduman R, Saxena, Ajit K, Dhar, Kanaya L
Publicado 2013

The HDAC/HSP90 Inhibitor G570 Attenuated Blue Light-Induced Cell Migration in RPE Cells and Neovascularization in Mice through Decreased VEGF Production

por Hsu, Tai-Ju, Nepali, Kunal, Tsai, Chi-Hao, Imtiyaz, Zuha, Lin, Fan-Li, Hsiao, George, Lai, Mei-Jung, Cheng, Yu-Wen
Publicado 2021

Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer

por Sharma, Sachin, Chandra, Kavya, Naik, Aliva, Sharma, Anamika, Sharma, Ram, Thakur, Amandeep, Grewal, Ajmer Singh, Dhingra, Ashwani K., Banerjee, Arnab, Liou, Jing Ping, Guru, Santosh Kumar, Nepali, Kunal
Publicado 2023

Antitumour, acute toxicity and molecular modeling studies of 4-(pyridin-4-yl)-6-(thiophen-2-yl) pyrimidin-2(1H)-one against Ehrlich ascites carcinoma and sarcoma-180

por Kumar, Dinesh, Sharma, Pooja, Nepali, Kunal, Mahajan, Girish, Mintoo, Mubashir J., Singh, Amarinder, Singh, Gurpreet, Mondhe, Dilip M., Singh, Gurdarshan, Jain, Subheet K., Gupta, Girish K., Ntie-Kang, Fidele
Publicado 2018